Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes

This secondary analysis of a multinational randomized clinical trial of 27  395 participants with systemic atherosclerotic disease examines the association low-dose rivaroxaban plus aspirin, rivaroxaban alone, or aspirin alone and the risk of different ischemic stroke subtypes.
Source: JAMA Neurology - Category: Neurology Source Type: research